(BRK-B) Berkshire Hathaway - Ratings and Ratios
Insurance, Rail, Utilities, Manufacturing, Retail
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 14.5% |
| Value at Risk 5%th | 23.5% |
| Relative Tail Risk | -1.45% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.23 |
| Alpha | -3.93 |
| CAGR/Max DD | 1.22 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.363 |
| Beta | 0.488 |
| Beta Downside | 0.505 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.95% |
| Mean DD | 3.90% |
| Median DD | 3.12% |
Description: BRK-B Berkshire Hathaway December 01, 2025
Berkshire Hathaway Inc. (BRK-B) is a conglomerate that spans insurance (property-casualty, life, health, reinsurance), freight rail (BNSF Railway), utilities (electric generation, transmission, natural-gas pipelines, LNG, and coal assets), and a broad array of manufacturing and consumer-product businesses ranging from confectionery to aerospace components and retail. The company’s decentralized structure allows each subsidiary to operate independently while contributing to a massive, cash-generating balance sheet.
Key quantitative highlights as of FY 2023 include: • Net earnings of $89.8 billion, driven largely by a 95.7 % combined ratio in the insurance segment and a 71.3 % operating ratio at BNSF Railway, both indicating strong underwriting discipline and efficient rail operations. • Utility cash flow of $12 billion, supported by rising demand for renewable generation (wind and solar now account for ~25 % of Berkshire’s utility capacity) and regulated rate-case outcomes. • A diversified revenue mix where roughly 55 % comes from insurance, 25 % from rail and utilities, and the remaining 20 % from manufacturing, retail and other businesses, providing resilience against sector-specific downturns.
If you want a data-rich, comparative view of Berkshire’s valuation metrics and how they stack up against peers, a quick look at ValueRay’s analyst dashboard can be a useful next step.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (67.46b TTM) > 0 and > 6% of Revenue (6% = 22.72b TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -0.26pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 126.7% (prev 82.06%; Δ 44.65pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 39.40b <= Net Income 67.46b (YES >=105%, WARN >=100%) |
| Net Debt (74.18b) to EBITDA (98.86b) ratio: 0.75 <= 3.0 (WARN <= 3.5) |
| Current Ratio 48.72 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.16b) change vs 12m ago 0.17% (target <= -2.0% for YES) |
| Gross Margin 28.69% (prev 56.21%; Δ -27.52pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 31.91% (prev 37.69%; Δ -5.79pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 20.03 (EBITDA TTM 98.86b / Interest Expense TTM 4.28b) >= 6 (WARN >= 3) |
Altman Z'' 6.51
| (A) 0.39 = (Total Current Assets 489.78b - Total Current Liabilities 10.05b) / Total Assets 1225.96b |
| (B) 0.61 = Retained Earnings (Balance) 743.99b / Total Assets 1225.96b |
| (C) 0.07 = EBIT TTM 85.65b / Avg Total Assets 1186.61b |
| (D) 1.41 = Book Value of Equity 741.47b / Total Liabilities 525.52b |
| Total Rating: 6.51 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 65.29
| 1. Piotroski 3.0pt |
| 2. FCF Yield 2.23% |
| 3. FCF Margin 5.10% |
| 4. Debt/Equity 0.21 |
| 5. Debt/Ebitda 0.75 |
| 6. ROIC - WACC (= 1.97)% |
| 7. RoE 10.10% |
| 8. Rev. Trend 38.05% |
| 9. EPS Trend 83.81% |
What is the price of BRK-B shares?
Over the past week, the price has changed by -2.06%, over one month by +3.19%, over three months by -0.73% and over the past year by +7.45%.
Is BRK-B a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BRK-B price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 528.7 | 5.1% |
| Analysts Target Price | 528.7 | 5.1% |
| ValueRay Target Price | 574.6 | 14.2% |
BRK-B Fundamental Data Overview December 03, 2025
P/E Trailing = 16.258
P/E Forward = 23.31
P/S = 2.9482
P/B = 1.5877
P/EG = 10.0559
Beta = 0.709
Revenue TTM = 378.61b USD
EBIT TTM = 85.65b USD
EBITDA TTM = 98.86b USD
Long Term Debt = 122.32b USD (from longTermDebt, last fiscal year)
Short Term Debt = 26.28b USD (from shortTermDebt, last quarter)
Debt = 150.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 74.18b USD (from netDebt column, last quarter)
Enterprise Value = 865.92b USD (1097.11b + Debt 150.48b - CCE 381.67b)
Interest Coverage Ratio = 20.03 (Ebit TTM 85.65b / Interest Expense TTM 4.28b)
FCF Yield = 2.23% (FCF TTM 19.33b / Enterprise Value 865.92b)
FCF Margin = 5.10% (FCF TTM 19.33b / Revenue TTM 378.61b)
Net Margin = 17.82% (Net Income TTM 67.46b / Revenue TTM 378.61b)
Gross Margin = 28.69% ((Revenue TTM 378.61b - Cost of Revenue TTM 269.97b) / Revenue TTM)
Gross Margin QoQ = 23.29% (prev 44.56%)
Tobins Q-Ratio = 0.71 (Enterprise Value 865.92b / Total Assets 1225.96b)
Interest Expense / Debt = 0.22% (Interest Expense 325.0m / Debt 150.48b)
Taxrate = 19.00% (7.24b / 38.10b)
NOPAT = 69.37b (EBIT 85.65b * (1 - 19.00%))
Current Ratio = 48.72 (Total Current Assets 489.78b / Total Current Liabilities 10.05b)
Debt / Equity = 0.21 (Debt 150.48b / totalStockholderEquity, last quarter 700.44b)
Debt / EBITDA = 0.75 (Net Debt 74.18b / EBITDA 98.86b)
Debt / FCF = 3.84 (Net Debt 74.18b / FCF TTM 19.33b)
Total Stockholder Equity = 668.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.50% (Net Income 67.46b / Total Assets 1225.96b)
RoE = 10.10% (Net Income TTM 67.46b / Total Stockholder Equity 668.07b)
RoCE = 10.84% (EBIT 85.65b / Capital Employed (Equity 668.07b + L.T.Debt 122.32b))
RoIC = 8.86% (NOPAT 69.37b / Invested Capital 783.18b)
WACC = 6.89% (E(1097.11b)/V(1247.60b) * Re(7.81%) + D(150.48b)/V(1247.60b) * Rd(0.22%) * (1-Tc(0.19)))
Discount Rate = 7.81% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.34%
[DCF Debug] Terminal Value 77.82% ; FCFE base≈20.01b ; Y1≈19.39b ; Y5≈19.32b
Fair Price DCF = 250.4 (DCF Value 343.80b / Shares Outstanding 1.37b; 5y FCF grow -4.27% → 3.0% )
EPS Correlation: 83.81 | EPS CAGR: 18.91% | SUE: 0.39 | # QB: 0
Revenue Correlation: 38.05 | Revenue CAGR: 31.74% | SUE: -0.05 | # QB: 0
EPS next Quarter (2026-03-31): EPS=5.51 | Chg30d=+0.234 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=24.19 | Chg30d=+2.466 | Revisions Net=+0 | Growth EPS=+13.7% | Growth Revenue=+1.7%
Additional Sources for BRK-B Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle